These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5599211)

  • 1. [Diabetic metabolic aberration after porto-systmeic shunt].
    Christensen MF
    Ugeskr Laeger; 1967 Feb; 129(6):195-8. PubMed ID: 5599211
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucose tolerance and insulinemia in patients with hepatic cirrhosis and portal hypertension treated by portacaval anastomosis].
    Postiglione A; Casaretti B; Masciariello S; Riccardi G; Perrotti N; Lamenza F; Porcellini M; Mattioli PL
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):331-7. PubMed ID: 399734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patients with liver cirrhosis and portal hypertension: survival after decompressive shunt operation].
    Vanermen H; Lepoutre L; Fevery J; Daenen W; Suy R; De Groote J; Stalpaert G
    Tijdschr Gastroenterol; 1978; 21(6):417-30. PubMed ID: 756100
    [No Abstract]   [Full Text] [Related]  

  • 4. [The outlook for cirrhotic patients after porto-caval anastomosis].
    Quinton A; Bancons J
    Bord Med; 1971 Dec; 4(12):1581-604. PubMed ID: 5316986
    [No Abstract]   [Full Text] [Related]  

  • 5. [The significance of diabetes mellitus in the indications for portacaval anastomosis in portal hypertension of liver cirrhosis].
    Esser G; Schreiber HW
    Langenbecks Arch Chir; 1965 Sep; 312(1):41-7. PubMed ID: 5880988
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of Child's criteria. Experience in the vascular surgery treatment of patients with liver cirrhosis and portal hypertension].
    Van Ermen H; Lepoutre L; Fevery J; Daenen W; Suy R; De Grootte J; Stalpaert G
    Tijdschr Gastroenterol; 1978; 21(5):313-24. PubMed ID: 756093
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of portal hypertension. Various aspects of minor pathology in the surgically treated cirrhotic patient].
    Masciariello S; Porcellini M; Zotti GC; De Sena G; Mancuso M
    Minerva Med; 1978 Apr; 69(17):1195-6. PubMed ID: 662148
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of a series of 23 porto-caval derivations in cirrhotic patients].
    Ribet M; Gautier-Benoit C; Quandalle P; Brenner A; Latreille JP; Razemon P
    Lille Med; 1970; 15(6):931-5. PubMed ID: 5465927
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative results of portacaval shunt operations in cirrhosis and non-cirrhotic portal fibrosis of the liver with severe portal hypertension.
    Basu AK; Laiq AW; Dhara P; Das Gupta R; Chatterjee A
    Indian J Med Res; 1972 Jun; 60(6):938-48. PubMed ID: 4660309
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extension of indications for portal shunt operation through the management of postoperative liver decompensation with peritoneal dialysis].
    Kraemer HJ
    Munch Med Wochenschr; 1968 Feb; 110(7):406-9. PubMed ID: 5695059
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of glucose regulation and blood insulin before and after porto-caval anastomosis].
    Azerad E; Lubetzki J; Duprey J; Friedler D
    Diabete; 1967; 15(1):50-6. PubMed ID: 6044410
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiopathological considerations on portacaval shunt].
    Liehr H; Zwirner R
    Minerva Med; 1973 Dec; 64(93):4951-4. PubMed ID: 4780525
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of hemodynamic studies in the evaluation of portal hypertension.
    Smith GW
    Am Surg; 1973 Jan; 39(1):40-7. PubMed ID: 4686134
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of hemosiderosis after side-to-side portacaval shunting.
    Baker JA; Cohen M
    Gastroenterology; 1972 Sep; 63(3):491-4. PubMed ID: 5071286
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies of the shunt indication in patients with portal hypertension].
    Bucher H; Fuchs WA; Tauber J; Rösler H; Preisig R
    Schweiz Med Wochenschr; 1969 Feb; 99(7):229-38. PubMed ID: 5769267
    [No Abstract]   [Full Text] [Related]  

  • 16. [The surgical treatment of portal hypertension].
    Tadzhiev KT; Usmanov NU; Smirnova LF
    Khirurgiia (Mosk); 1965 Nov; 41(11):43-7. PubMed ID: 5879083
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observations of the course of several liver function tests following shunt operations in portal hypertension].
    Brunner L; Hoffmeister HE; Köhn U; Koncz J
    Med Klin; 1966 Jan; 61(2):55-60. PubMed ID: 4166908
    [No Abstract]   [Full Text] [Related]  

  • 18. [Variations in the numbers of thrombocytes and leukocytes in cirrhotic patients with portacaval shunt].
    Karády G; Karácsonyi S; Stekker K; Szloboda J; Szécsény A
    Acta Chir Acad Sci Hung; 1969; 10(3):325-9. PubMed ID: 5310101
    [No Abstract]   [Full Text] [Related]  

  • 19. The results and complications of the surgical treatment of portal hypertension due to cirrhosis of the liver.
    Hunt AH
    Br J Clin Pract; 1966 Dec; 20(12):607-10. PubMed ID: 5974497
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatic encephalopathy in surgical treatment of patients with portal hypertension].
    Lebezev VM; Gubskiĭ LV; Tachmuradova GT; Dolidze MA
    Klin Med (Mosk); 1995; 73(2):37-9. PubMed ID: 7609415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.